Genitourinary Malignancies Research Center, Lerner Research Institute.
Center for Clinical Genomics, Genomics Medicine Institute.
Eur J Endocrinol. 2022 May 12;187(1):1-14. doi: 10.1530/EJE-21-0996.
A sex discordance in COVID exists, with males disproportionately affected. Although sex steroids may play a role in this discordance, no definitive genetic data exist to support androgen-mediated immune suppression neither for viral susceptibility nor for adrenally produced androgens.
The common adrenal-permissive missense-encoding variant HSD3B1(1245C) that enables androgen synthesis from adrenal precursors and that has been linked to suppression of inflammation in severe asthma was investigated in COVID susceptibility and outcomes reported in the UK Biobank.
The UK Biobank is a long-term study with detailed medical information and health outcomes for over 500 000 genotyped individuals. We obtained COVID test results, inpatient hospital records, and death records and tested for associations between COVID susceptibility or outcomes and HSD3B1(1245A/C) genotype. Primary analyses were performed on the UK Biobank Caucasian cohort. The outcomes were identification as a COVID case among all subjects, COVID positivity among COVID-tested subjects, and mortality among subjects identified as COVID cases.
Adrenal-permissive HSD3B1(1245C) genotype was associated with identification as a COVID case (odds ratio (OR): 1.11 per C allele, 95% CI: 1.04-1.18, P = 0.0013) and COVID-test positivity (OR: 1.09, 95% CI: 1.02-1.17, P = 0.011) in older (≥70 years of age) women. In women identified as COVID cases, there was a positive linear relationship between age and 1245C allele frequency (P < 0.0001). No associations were found between genotype and mortality or between genotype and circulating sex hormone levels.
Our study suggests that a common androgen synthesis variant regulates immune susceptibility to COVID infection in women, with increasingly strong effects as women age.
新冠病毒存在性别差异,男性受影响更为严重。尽管性激素可能在这种差异中起作用,但目前尚无明确的遗传数据支持雄激素介导的免疫抑制作用,无论是针对病毒易感性还是针对肾上腺产生的雄激素。
本研究旨在调查与严重哮喘炎症抑制相关的常见肾上腺允许型错义编码变异 HSD3B1(1245C),该变异可促进雄激素从肾上腺前体合成,并探讨其与英国生物银行报告的新冠病毒易感性和结局之间的关系。
英国生物银行是一项长期研究,对超过 50 万名基因分型个体的详细医疗信息和健康结局进行了研究。我们获得了新冠病毒检测结果、住院记录和死亡记录,并检测了 HSD3B1(1245A/C)基因型与新冠易感性或结局之间的关联。主要分析在英国生物银行的白种人群体中进行。结局包括所有受试者中被确定为新冠病例、新冠检测阳性受试者中的新冠阳性率以及被确定为新冠病例的受试者中的死亡率。
肾上腺允许型 HSD3B1(1245C)基因型与女性(年龄≥70 岁)被确定为新冠病例(优势比[OR]:每 C 等位基因 1.11,95%置信区间[CI]:1.04-1.18,P = 0.0013)和新冠检测阳性(OR:1.09,95% CI:1.02-1.17,P = 0.011)相关。在被确定为新冠病例的女性中,年龄与 1245C 等位基因频率之间呈正线性关系(P < 0.0001)。未发现基因型与死亡率或基因型与循环性激素水平之间存在关联。
本研究表明,一种常见的雄激素合成变异可调节女性对新冠病毒感染的免疫易感性,且随着女性年龄的增长,其影响越来越大。